Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$751M |
| 2 |
Home Depot
HD
|
+$408M |
| 3 |
Altria Group
MO
|
+$378M |
| 4 |
SMBS
Schwab Mortgage-Backed Securities ETF
SMBS
|
+$298M |
| 5 |
Texas Instruments
TXN
|
+$260M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$868M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$819M |
| 3 |
Amgen
AMGN
|
+$552M |
| 4 |
Merck
MRK
|
+$482M |
| 5 |
Cisco
CSCO
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.87% |
| 2 | Financials | 11.48% |
| 3 | Healthcare | 9.94% |
| 4 | Consumer Discretionary | 9.29% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Harmony Biosciences
HRMY
$2.24B
| $15.6M | ﹤0.01% |
417,955
-38,446
| -8% | -$1.26M |
|
1902
BioCryst Pharmaceuticals
BCRX
$2.51B
| $15.6M | ﹤0.01% |
2,004,939
+10,535
| +0.5% | +$76.2K |
|
1903
Summit Therapeutics
SMMT
$11.2B
| $15.6M | ﹤0.01% |
892,629
+16,239
| +2% | +$306K |
|
1904
FirstService
FSV
$6.18B
| $15.6M | ﹤0.01% |
100,165
+2,634
| +3% | +$429K |
|
1905
Nomad Foods
NOMD
$1.68B
| $15.6M | ﹤0.01% |
1,244,735
+94,340
| +8% | +$1.15M |
|
1906
nLIGHT
LASR
$2.9B
| $15.6M | ﹤0.01% |
414,861
+6,224
| +2% | +$208K |
|
1907
Lindsay Corp
LNN
$1.17B
| $15.5M | ﹤0.01% |
131,636
-8,001
| -6% | -$963K |
|
1908
SunCoke Energy
SXC
$788M
| $15.5M | ﹤0.01% |
2,153,408
+503,500
| +31% | +$3.71M |
|
1909
OR Royalties Inc
OR
$6.15B
| $15.4M | ﹤0.01% |
435,397
+9,723
| +2% | +$341K |
|
1910
Koppers
KOP
$874M
| $15.4M | ﹤0.01% |
568,413
+22,114
| +4% | +$618K |
|
1911
IDT Corp
IDT
$1.67B
| $15.3M | ﹤0.01% |
299,718
+10,345
| +4% | +$518K |
|
1912
REX American Resources
REX
$1.44B
| $15.3M | ﹤0.01% |
473,821
+35,530
| +8% | +$1.16M |
|
1913
Surgery Partners
SGRY
$1.99B
| $15.3M | ﹤0.01% |
990,648
+59,983
| +6% | +$1.1M |
|
1914
Syndax Pharmaceuticals
SNDX
$1.7B
| $15.3M | ﹤0.01% |
727,424
+8,390
| +1% | +$146K |
|
1915
Constellium
CSTM
$3.95B
| $15.2M | ﹤0.01% |
808,857
-13,847
| -2% | -$230K |
|
1916
Standard Motor Products
SMP
$870M
| $15.2M | ﹤0.01% |
412,671
+51,918
| +14% | +$1.99M |
|
1917
nCino
NCNO
$2.26B
| $15.2M | ﹤0.01% |
592,684
-55,175
| -9% | -$1.4M |
|
1918
Ceco Environmental
CECO
$4.5B
| $15.2M | ﹤0.01% |
253,726
+3,717
| +1% | +$199K |
|
1919
Digi International
DGII
$3.23B
| $15.2M | ﹤0.01% |
350,663
-675
| -0.2% | -$27K |
|
1920
BJ's Restaurants
BJRI
$1.42B
| $15.2M | ﹤0.01% |
385,230
+30,269
| +9% | +$1.08M |
|
1921
Edgewise Therapeutics
EWTX
$4.69B
| $15.2M | ﹤0.01% |
611,384
+13,781
| +2% | +$277K |
|
1922
Intuitive Machines
LUNR
$2.82B
| $15.1M | ﹤0.01% |
933,096
+10,582
| +1% | +$123K |
|
1923
Metallus
MTUS
$892M
| $15.1M | ﹤0.01% |
881,941
+130,752
| +17% | +$2.24M |
|
1924
Enact Holdings
ACT
$6.84B
| $15.1M | ﹤0.01% |
381,694
+23,827
| +7% | +$897K |
|
1925
Payoneer
PAYO
$2.42B
| $15.1M | ﹤0.01% |
2,689,584
+16,650
| +0.6% | +$96.2K |
|
Similar funds
Charles Schwab's Q4 2025 Portfolio in Review
As of Q4 2025, Charles Schwab held 3,523 positions worth $644B, up 2.7% from $626B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q4 2025: portfolio turnover was 3.8%. Charles Schwab opened 68 new positions and exited 67, leaving the 3,523-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2025 buy was Qnity Electronics Inc: 1,489,517 shares worth $122M.
- Charles Schwab added most to Meta Platforms (Facebook) in Q4 2025, an estimated $751M increase.
- Charles Schwab's biggest Q4 2025 reduction was Broadcom, cutting an estimated $868M.
- Charles Schwab fully exited Vanguard S&P 500 ETF in Q4 2025, selling an estimated $819M.
- Charles Schwab's ten largest holdings make up 25% of its $644B portfolio in Q4 2025.
- Charles Schwab opened 68 new positions and closed 67 in Q4 2025.
- Charles Schwab's portfolio value rose 2.7% quarter-over-quarter to $644B.
Based on Charles Schwab's 13F filing for Q4 2025, filed 13 Feb 2026.